ETHNOPHARMACOLOGICAL RELEVANCE: Arrabidaea chica Verlot. (Bignoniaceae), popularly known as Crajiru, has been traditionally used as wound healing agent. AIM OF THE STUDY: Investigate in vitro and in vivo healing properties of Arrabidaea chica leaves extract (AC). MATERIALS AND METHODS: AC was evaluated in vitro in fibroblast growth stimulation (0.25-250 microg/mL) and collagen production stimulation (250 microg/mL) assays. Allantoin (0.25-250 microg/mL) and vitamin C (25 microg/mL) were used as controls respectively. DPPH and Folin-Ciocalteau assays were used for antioxidant evaluation, using trolox (0.25-250 microg/mL) as reference antioxidant. To study wound healing properties in rats, AC (100mg/mL, 200 microL/wound/day) was topically administered during 10 days and wound area was evaluated every day. Allantoin (100mg/mL, 200 microL/wound/day) was used as standard drug. After treatment, wound sites were removed for histopathological analysis and total collagen determination. RESULTS: AC stimulated fibroblast growth in a concentration dependent way (EC50=30 microg/mL), increased in vitro collagen production and demonstrated moderate antioxidant capacity. In vivo, AC reduced wound size in 96%, whereas saline group showed only 36% wound healing. CONCLUSION: AC efficiency seems to involve fibroblast growing stimulus and collagen synthesis both in vitro and in vivo, beyond moderate scavenging activity, corroborating Crajiru folk use.
ETHNOPHARMACOLOGICAL RELEVANCE: Arrabidaea chica Verlot. (Bignoniaceae), popularly known as Crajiru, has been traditionally used as wound healing agent. AIM OF THE STUDY: Investigate in vitro and in vivo healing properties of Arrabidaea chica leaves extract (AC). MATERIALS AND METHODS:AC was evaluated in vitro in fibroblast growth stimulation (0.25-250 microg/mL) and collagen production stimulation (250 microg/mL) assays. Allantoin (0.25-250 microg/mL) and vitamin C (25 microg/mL) were used as controls respectively. DPPH and Folin-Ciocalteau assays were used for antioxidant evaluation, using trolox (0.25-250 microg/mL) as reference antioxidant. To study wound healing properties in rats, AC (100mg/mL, 200 microL/wound/day) was topically administered during 10 days and wound area was evaluated every day. Allantoin (100mg/mL, 200 microL/wound/day) was used as standard drug. After treatment, wound sites were removed for histopathological analysis and total collagen determination. RESULTS:AC stimulated fibroblast growth in a concentration dependent way (EC50=30 microg/mL), increased in vitro collagen production and demonstrated moderate antioxidant capacity. In vivo, AC reduced wound size in 96%, whereas saline group showed only 36% wound healing. CONCLUSION:AC efficiency seems to involve fibroblast growing stimulus and collagen synthesis both in vitro and in vivo, beyond moderate scavenging activity, corroborating Crajiru folk use.
Authors: Lucas Buzeli de Souza; Jennyffer Ione de Souza Silva; Leonardo Bagne; Amanda Tavares Pereira; Maraiara Aparecida de Oliveira; Bruno Bellotti Lopes; Maria Esméria Corezola do Amaral; Andrea Aparecida de Aro; Marcelo Augusto Marretto Esquisatto; Gláucia Maria Tech Dos Santos; Thiago Antônio Moretti de Andrade Journal: Inflammation Date: 2020-12 Impact factor: 4.092
Authors: Rogério Marchete; Sarah Oliveira; Leonardo Bagne; Jennyffer Ione de Souza Silva; Ana Paula Valverde; Andrea Aparecida de Aro; Mariana Moreira Figueira; Marcio Fronza; Thainá Mikaela Bressam; Vivian Fernandes Furletti de Goes; Fernanda Oliveira de Gaspari de Gaspi; Gláucia Maria Tech Dos Santos; Thiago Antônio Moretti Andrade Journal: Inflammopharmacology Date: 2021-09-21 Impact factor: 4.473
Authors: Benedito Junior Lima de Medeiros; Kelém Dos Santos Costa; Jeane Francisca Alves Ribeiro; José Otavio Carrera Silva; Wagner Luiz Ramos Barbosa; José Carlos Tavares Carvalho Journal: Pharmacognosy Res Date: 2011-04
Authors: Leila Servat-Medina; Alvaro González-Gómez; Felisa Reyes-Ortega; Ilza Maria Oliveira Sousa; Nubia de Cássia Almeida Queiroz; Patricia Maria Wiziack Zago; Michelle Pedrosa Jorge; Karin Maia Monteiro; João Ernesto de Carvalho; Julio San Román; Mary Ann Foglio Journal: Int J Nanomedicine Date: 2015-06-09